JAK Inhibitor Tapering in Rheumatoid Arthritis: Implications for Patients in Sustained Remission
Data suggest that patients in remission with baricitinib 4 mg daily dose who have taken this medication for at least 1 year may be able to attempt baricitinib dose-tapering while continuing their methotrexate regimen.
